Acetic Acid → HCID 59837410, compound
Reaction equation
[N:1]1([C:7]([C:9]2([C:15]3[CH:31]=[CH:30][C:18]([O:19][CH2:20][CH2:21][CH2:22][N:23]4[CH2:29][CH2:28][CH2:27][O:26][CH2:25][CH2:24]4)=[CH:17][CH:16]=3)[CH2:14][CH2:13][O:12][CH2:11][CH2:10]2)=[O:8])[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.C=O.[C:34](O)(=O)C>C(Cl)Cl>[CH3:34][N:4]1[CH2:3][CH2:2][N:1]([C:7]([C:9]2([C:15]3[CH:16]=[CH:17][C:18]([O:19][CH2:20][CH2:21][CH2:22][N:23]4[CH2:29][CH2:28][CH2:27][O:26][CH2:25][CH2:24]4)=[CH:30][CH:31]=3)[CH2:10][CH2:11][O:12][CH2:13][CH2:14]2)=[O:8])[CH2:6][CH2:5]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
4-(3-{4-[4-(piperazin-1-ylcarbonyl)tetrahydro-2H-pyran-4-yl]phenoxy}propyl)-1,4-oxazepane (45 mg, 0.1 mmol) was dissolved in DCM (3 ml), to which was added formaldehyde (37% w/w in H2O, 12 mg, 0.12 mmol) and acetic acid (8 mg, 0.12 mmol) and was stirred at room temperature for 30 minutes before adding STAB (25 mg, 0.12 mmol). The solution was allowed to stir for a further 45 minutes before washing the solution with saturated sodium bicarbonate (10 ml), followed by brine (10 ml). The organic layer was dried over Na2SO4 and concentrated in vacuo to afford the title compound as a white solid (25 mg, 56%). 1H NMR (400 MHz, d6-DMSO) δ 1.76-2.13 (m, 11H), 2.55-2.78 (m, 6H), 3.16-3.39 (m, 8H), 3.50-3.62 (m, 4H), 3.63 (m, 2H), 3.72 (M, 2H), 3.99 (t, 2H), 6.92 (d, 2H), 7.12 (d, 2H). LRMS ESI+ m/z 446 [MH]+.
Workup
- additionbefore adding STAB (25 mg, 0.12 mmol)
- stirringto stir for a further 45 minutes
- washbefore washing the solution with saturated sodium bicarbonate (10 ml)
- dry with materialThe organic layer was dried over Na2SO4
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-b04fa1eed31e4f008b479f363bebe1a8
- Source dataset
- uspto-grants-2008_11
- Patent number
- US07456164B2
Reaction notes
Loading…